InvestorsHub Logo

resx18

10/12/15 9:12 AM

#8381 RE: resx18 #8380

$VRCI is pleased to announce that along with some renowned research scientists it intends to study the treatment potential of a cannabis preparation (Nabiximols) in the treatment of Huntingdon's Disease as a sponsor at 2 universities in North America. The study as currently designed will be a double-blind, placebo controlled protocol with 48 subjects.

Read more: http://www.nasdaq.com/press-release/verde-science-announces-plan-to-study-cannabis-preparation-for-treatment-of-huntingdons-disease-20151009-00487#ixzz3oMJb5wX1